GeNO

The CenterWatch Monthly, May 2011

Monday, May 2, 2011 11:05 AM

Sites worldwide rate PPD, Kendle, ICON top CROs

More... »


Genomic launches breast cancer trial

Wednesday, April 27, 2011 02:01 PM

Genomic Health has launched RxPONDER S1007, a breast cancer clinical trial being led by SWOG, one of the National Cancer Institute’s (NCI) cancer cooperative groups.  The trial is designed to determine the effect of chemotherapy in breast cancer patients with one to three positive nodes who have a Recurrence Score (RS) result equal to, or less than, 25 as determined by the Oncotype DX breast cancer test.

More... »


Anadys appoints Barry Labinger to board of directors

Friday, March 18, 2011 10:44 AM

Anadys Pharmaceuticals has appointed Barry A. Labinger to its board of directors. Labinger is executive vice president and chief commercial officer of Human Genome Sciences.

More... »

Human Genome partners with FivePrime

Thursday, March 17, 2011 12:25 PM

Human Genome Sciences said it will develop and commercialize a drug for multiple cancers from FivePrime Therapeutics in the U.S., Canada and European markets, according to a Reuters report.

More... »

Genetics remains at top of academic research

Friday, March 11, 2011 01:51 PM

Genetics is still the hottest area of scientific research, a decade since the mapping of the human genome, despite slow progress in translating discoveries into new medical treatments, according to a report in Reuters.

More... »

CRO QPS acquires Qualitix

Wednesday, March 9, 2011 01:28 PM

QPS, a global GLP/GCP-compliant CRO providing testing services for preclinical and clinical R&D, has acquired a majority interest of Qualitix Clinical Research. Qualitix, a spin-off of Taiwan-based biotech Genovate, is a CRO and site management organization (SMO) with offices in Taiwan and China. Genovate will retain a minority interest in Qualitix, which will be known as QPS-Qualitix Taiwan.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.